OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy
Mansoor Khaledi, Fatemeh Sameni, Sheida Yahyazade, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 14
Mansoor Khaledi, Fatemeh Sameni, Sheida Yahyazade, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 14
Showing 14 citing articles:
Small molecule drug discovery targeting the JAK-STAT pathway
You Lv, Pengbing Mi, Jeffrey J. Babon, et al.
Pharmacological Research (2024) Vol. 204, pp. 107217-107217
Open Access | Times Cited: 12
You Lv, Pengbing Mi, Jeffrey J. Babon, et al.
Pharmacological Research (2024) Vol. 204, pp. 107217-107217
Open Access | Times Cited: 12
Mesenchymal stem cells and their extracellular vesicle therapy for neurological disorders: traumatic brain injury and beyond
Aref Yarahmadi, Masoumeh Dorri Giv, Reza Hosseininejad, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access | Times Cited: 1
Aref Yarahmadi, Masoumeh Dorri Giv, Reza Hosseininejad, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access | Times Cited: 1
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
Nem Kumar Jain, Mukul Tailang, Hemant Kumar Jain, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Nem Kumar Jain, Mukul Tailang, Hemant Kumar Jain, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy
Mohamad Mahjoor, Golnaz Mahmoudvand, Simin Farokhi, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Mohamad Mahjoor, Golnaz Mahmoudvand, Simin Farokhi, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Recent advances in JAK inhibitors for the treatment of metabolic syndrome
Debora Collotta, Maria Paola Franchina, V. Carlucci, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Debora Collotta, Maria Paola Franchina, V. Carlucci, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Identification of Acanthopanax trifoliatus (L.) Merr as a Novel Potential Therapeutic Agent Against COVID-19 and Pharyngitis
Chen Qi, Hui He, Yanghong Zhu, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 1055-1055
Open Access
Chen Qi, Hui He, Yanghong Zhu, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 1055-1055
Open Access
Infection-Simulator, Immunostimulatory and Immunomodulatory Effects of Interferons I and III in Biological Systems: A New Era in Vaccinology and Therapeutics Possible?
Theodor-Nicolae Carp, Michael Metoudi, Vanshika Ojha
(2024)
Open Access | Times Cited: 3
Theodor-Nicolae Carp, Michael Metoudi, Vanshika Ojha
(2024)
Open Access | Times Cited: 3
Mechanistic Insights into Targeting SARS-CoV-2 Papain-like Protease in the Evolution and Management of COVID-19
Nonjabulo Ntombikhona Magwaza, Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, et al.
BioChem (2024) Vol. 4, Iss. 3, pp. 268-299
Open Access | Times Cited: 2
Nonjabulo Ntombikhona Magwaza, Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, et al.
BioChem (2024) Vol. 4, Iss. 3, pp. 268-299
Open Access | Times Cited: 2
Network-based Multi-omics Disease–Drug Associations Reveal Drug Repurposing Candidates for Covid-19 Disease Phases
Francis E. Agamah, Thomas H. A. Ederveen, Michelle Skelton, et al.
Drug repurposing (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 1
Francis E. Agamah, Thomas H. A. Ederveen, Michelle Skelton, et al.
Drug repurposing (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 1
PARP7i Clinical Candidate RBN‐2397 Exerts Antiviral Activity by Modulating Interferon‐β Associated Innate Immune Response in Macrophages
Xiaoli Du, Jiawei Zhou, Yi Zhou, et al.
Drug Development Research (2024) Vol. 85, Iss. 7
Closed Access | Times Cited: 1
Xiaoli Du, Jiawei Zhou, Yi Zhou, et al.
Drug Development Research (2024) Vol. 85, Iss. 7
Closed Access | Times Cited: 1
Infection of the oral cavity with SARS-CoV-2 variants: Scope of salivary diagnostics
Parvati Iyer, Takahiro Chino, David M. Ojcius
Frontiers in Oral Health (2022) Vol. 3
Open Access | Times Cited: 5
Parvati Iyer, Takahiro Chino, David M. Ojcius
Frontiers in Oral Health (2022) Vol. 3
Open Access | Times Cited: 5
Network-based multi-omics-disease-drug associations reveal drug repurposing candidates for COVID-19 disease phases
Francis E. Agamah, Thomas H. A. Ederveen, Michelle Skelton, et al.
(2024)
Open Access
Francis E. Agamah, Thomas H. A. Ederveen, Michelle Skelton, et al.
(2024)
Open Access
The activation of AIM2/Caspase-1/GSDMD pathway contributes to pyroptosis of keratinocytes in Stevens-Johnson syndrome/toxic epidermal necrolysis
Lu Yang, Yanhong Shou, Feng Li, et al.
Research Square (Research Square) (2023)
Open Access
Lu Yang, Yanhong Shou, Feng Li, et al.
Research Square (Research Square) (2023)
Open Access
Extrapulmonary Manifestations of COVID-19 in Mild/ Severe Patients
Fatemeh Sameni, Arash Khorram, Nooshin Nazarinejad, et al.
International Journal of Enteric Pathogens (2022) Vol. 10, Iss. 4, pp. 129-139
Open Access
Fatemeh Sameni, Arash Khorram, Nooshin Nazarinejad, et al.
International Journal of Enteric Pathogens (2022) Vol. 10, Iss. 4, pp. 129-139
Open Access
